Search research articles
Contact Us
Filters
Showing results (121-130 of 195) with videos related to
Page
of 20
Sort By:
Journal of the American Heart Association
|
March 12, 2018
Predictive Value of the Sequential Organ Failure Assessment Score for Mortality in a Contemporary Cardiac Intensive Care Unit Population
Jacob C Jentzer, Courtney Bennett, Brandon M Wiley, et al.
Lancet (London, England)
|
October 31, 2003
Eosinophilic-lymphocytic myocarditis after smallpox vaccination
Joseph G Murphy, R Scott Wright, G Keith Bruce, et al.
Diabetes Care
|
November 30, 2018
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Lawrence A Leiter, Hwee Teoh, David Kallend, et al.
Mayo Clinic Proceedings
|
January 8, 2021
Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists
Maria I Lapid, Karen M Meagher, Hannah C Giunta, et al.
International Journal of Cardiology
|
July 27, 2005
Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death
Anil Nigam, R Scott Wright, Thomas G Allison, et al.
The American Journal of Cardiology
|
September 20, 2018
Comparison of Mortality Risk Prediction Among Patients ≥70 Versus <70 Years of Age in a Cardiac Intensive Care Unit
Jacob C Jentzer, Dennis H Murphree, Brandon Wiley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, et al.
Mayo Clinic Proceedings
|
August 2, 2024
Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials
R Scott Wright, Kausik K Ray, Ulf Landmesser, et al.
Diabetes, Obesity & Metabolism
|
May 17, 2024
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials
Lawrence A Leiter, Frederick J Raal, Gregory G Schwartz, et al.
Atherosclerosis
|
November 28, 2023
Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials
Ulf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 195) with videos related to
Sort By:
Page
of 20
Journal of the American Heart Association
|
March 12, 2018
Predictive Value of the Sequential Organ Failure Assessment Score for Mortality in a Contemporary Cardiac Intensive Care Unit Population
Jacob C Jentzer, Courtney Bennett, Brandon M Wiley, et al.
Lancet (London, England)
|
October 31, 2003
Eosinophilic-lymphocytic myocarditis after smallpox vaccination
Joseph G Murphy, R Scott Wright, G Keith Bruce, et al.
Diabetes Care
|
November 30, 2018
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Lawrence A Leiter, Hwee Teoh, David Kallend, et al.
Mayo Clinic Proceedings
|
January 8, 2021
Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists
Maria I Lapid, Karen M Meagher, Hannah C Giunta, et al.
International Journal of Cardiology
|
July 27, 2005
Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death
Anil Nigam, R Scott Wright, Thomas G Allison, et al.
The American Journal of Cardiology
|
September 20, 2018
Comparison of Mortality Risk Prediction Among Patients ≥70 Versus <70 Years of Age in a Cardiac Intensive Care Unit
Jacob C Jentzer, Dennis H Murphree, Brandon Wiley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, et al.
Mayo Clinic Proceedings
|
August 2, 2024
Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials
R Scott Wright, Kausik K Ray, Ulf Landmesser, et al.
Diabetes, Obesity & Metabolism
|
May 17, 2024
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials
Lawrence A Leiter, Frederick J Raal, Gregory G Schwartz, et al.
Atherosclerosis
|
November 28, 2023
Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials
Ulf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
Page
of 20